Peptides for energy might help counter this metabolic slowdown
A clinician chooses among them based on the patient, the product label, access, and medical history
Here are some important points to keep in mind: Risk of Low Blood Sugar When Ozempic is combined with medications that increase insulin, like sulfonylureas or insulin itself, there is a higher chance of hypoglycemia
That matters for patient access and long-term adherence
There were no differences in older patients with or without comorbidities in either the LixiLan-O or LixiLan-L trials, except for slightly greater weight loss in patients with versus without comorbidities in the LixiLan-O trial (data on file)
Jeppesen PB, Lund P, Gottschalck IB, et al